Amgen Middle East Regulatory Affairs Director Adel Djalal On Drug Pricing And Regulatory Environment - An Interview With PharmAsia News (Part 2 of 2)
This article was originally published in PharmAsia News
Executive Summary
Amgen is targeting the Middle East as a new growth area, and it plans to venture further into Gulf countries, from Saudi Arabia and war-torn Iraq to countries like Algeria and Libya.